CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Nifedipine

硝苯地平 杂质对照品Nifedipine Impurities

EP46 个杂质条目46 impurity entries

本页汇总 硝苯地平 的 46 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 46 impurity reference standards of Nifedipine with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 硝苯地平(Nifedipine)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studies[Determination of trace genotoxic impurities in nifedipine by ultra high performance liquid chromatography-electrostatic field orbitrap high resolution mass spectrometry]
    Se pu = Chinese journal of chromatography · 2022 · Guo C et al.  ·  PMID 35243836  ·  DOI
  2. 杂质研究Impurity studiesDetermination of nitrobenzene potential genotoxic impurities in nifedipine with GC-MS
    Journal of pharmaceutical and biomedical analysis · 2024 · Zhao X et al.  ·  PMID 38852298  ·  DOI
  3. 杂质研究Impurity studiesDevelopment and Characterization of Different Dosage Forms of Nifedipine/Indomethacin Fixed-Dose Combinations
    Journal of drug delivery science and technology · 2023 · Althobaiti AA et al.  ·  PMID 36741268  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisSynthesis of Dihydropyrimidines: Isosteres of Nifedipine and Evaluation of Their Calcium Channel Blocking Efficiency
    Molecules (Basel, Switzerland) · 2023 · Zohny YM et al.  ·  PMID 36677842  ·  DOI
  • 合成方法SynthesisEffect of nifedipine on proliferation and DNA synthesis of human gingival fibroblasts
    The Chinese journal of dental research · 2000 · Sun W et al.  ·  PMID 11314088

硝苯地平 —— 原料药与杂质对照品Nifedipine — drug substance & impurities

共 47 个条目(含原料药本体)47 items incl. the drug substance
Nifedipine structure
EP原料药 APIAPI
硝苯地平Nifedipine
Nifedipine
CAS No.21829-25-4
Chemical FormulaC17H18N2O6
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 1 (Nifedipine EP Impurity A) structure
EPA
硝苯地平杂质1 (硝苯地平EP杂质A)Nifedipine Impurity 1 (Nifedipine EP Impurity A)
Nifedipine Impurity 1 (Nifedipine EP Impurity A)
CAS No.67035-22-7
Chemical FormulaC17H16N2O6
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 2 (Nifedipine EP Impurity B) structure
EPB
硝苯地平杂质2 (硝苯地平EP杂质B)Nifedipine Impurity 2 (Nifedipine EP Impurity B)
Nifedipine Impurity 2 (Nifedipine EP Impurity B)
CAS No.50428-14-3
Chemical FormulaC17H16N2O5
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 4 (Nifedipine EP Impurity C) structure
EPC
硝苯地平杂质4 (硝苯地平EP杂质C)Nifedipine Impurity 4 (Nifedipine EP Impurity C)
Nifedipine Impurity 4 (Nifedipine EP Impurity C)
CAS No.39562-27-1
Chemical FormulaC12H11NO5
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 5 (Nifedipine EP Impurity D) structure
EPD
硝苯地平杂质5 (硝苯地平EP杂质D)Nifedipine Impurity 5 (Nifedipine EP Impurity D)
Nifedipine Impurity 5 (Nifedipine EP Impurity D)
CAS No.14205-39-1
Chemical FormulaC5H9NO2
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 3 structure
3
硝苯地平杂质3Nifedipine Impurity 3
Nifedipine Impurity 3
CAS No.88434-69-9
Chemical FormulaC17H16N2O7
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 6 structure
6
硝苯地平杂质6Nifedipine Impurity 6
Nifedipine Impurity 6
CAS No.21829-26-5
Chemical FormulaC19H22N2O6
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 7 structure
7
硝苯地平杂质7Nifedipine Impurity 7
Nifedipine Impurity 7
CAS No.74378-10-2
Chemical FormulaC15H14N2O6
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 8 structure
8
硝苯地平杂质8Nifedipine Impurity 8
Nifedipine Impurity 8
CAS No.114709-68-1
Chemical FormulaC16H17N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 9 structure
9
硝苯地平杂质9Nifedipine Impurity 9
Nifedipine Impurity 9
CAS No.74936-71-3
Chemical FormulaC16H16N2O6
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 10 (Mixture of E/Z-isomers) structure
10
硝苯地平杂质10 (混合E/Z构型)Nifedipine Impurity 10 (Mixture of E/Z-isomers)
Nifedipine Impurity 10 (Mixture of E/Z-isomers)
CAS No.15846-25-0
Chemical FormulaC4H8N2O
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 11 structure
11
硝苯地平杂质11Nifedipine Impurity 11
Nifedipine Impurity 11
CAS No.39562-17-9
Chemical FormulaC12H11NO5
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 12 structure
12
硝苯地平杂质12Nifedipine Impurity 12
Nifedipine Impurity 12
CAS No.74936-81-5
Chemical FormulaC15H14N2O6
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 13 (Mixture of E/Z-isomers) structure
13
硝苯地平杂质13 (混合E/Z构型)Nifedipine Impurity 13 (Mixture of E/Z-isomers)
Nifedipine Impurity 13 (Mixture of E/Z-isomers)
CAS No.80742-11-6
Chemical FormulaC19H18N4O6
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 14 structure
14
硝苯地平杂质14Nifedipine Impurity 14
Nifedipine Impurity 14
CAS No.3958-60-9
Chemical FormulaC7H6BrNO2
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 15 structure
15
硝苯地平杂质15Nifedipine Impurity 15
Nifedipine Impurity 15
CAS No.612-25-9
Chemical FormulaC7H7NO3
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 16 structure
16
硝苯地平杂质16Nifedipine Impurity 16
Nifedipine Impurity 16
CAS No.552-89-6
Chemical FormulaC7H5NO3
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 17 structure
17
硝苯地平杂质17Nifedipine Impurity 17
Nifedipine Impurity 17
CAS No.555-16-8
Chemical FormulaC7H5NO3
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 19 structure
19
硝苯地平杂质19Nifedipine Impurity 19
Nifedipine Impurity 19
CAS No.20357-21-5
Chemical FormulaC7H4BrNO3
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 20 structure
20
硝苯地平杂质20Nifedipine Impurity 20
Nifedipine Impurity 20
CAS No.5551-12-2
Chemical FormulaC7H4BrNO3
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 21 structure
21
硝苯地平杂质21Nifedipine Impurity 21
Nifedipine Impurity 21
CAS No.27178-83-2
Chemical FormulaC7H5NO4
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 22 structure
22
硝苯地平杂质22Nifedipine Impurity 22
Nifedipine Impurity 22
CAS No.167710-84-1
Chemical FormulaC17H18N2O5
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 23 structure
23
硝苯地平杂质23Nifedipine Impurity 23
Nifedipine Impurity 23
CAS No.17438-14-1
Chemical FormulaC11H15NO4
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 28 structure
28
硝苯地平杂质28Nifedipine Impurity 28
Nifedipine Impurity 28
CAS No.34785-00-7
Chemical FormulaC16H12N2O6
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 29 structure
29
硝苯地平杂质29Nifedipine Impurity 29
Nifedipine Impurity 29
CAS No.21829-09-4
Chemical FormulaC17H18N2O6
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 30 (Mixture of cis and trans Isomers) structure
30
硝苯地平杂质30 (混合顺和反异构体)Nifedipine Impurity 30 (Mixture of cis and trans Isomers)
Nifedipine Impurity 30 (Mixture of cis and trans Isomers)
CAS No.108139-78-2
Chemical FormulaC19H18N4O6
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 31 (Mixture of E/Z-isomers) structure
31
硝苯地平杂质31 (混合E/Z构型)Nifedipine Impurity 31 (Mixture of E/Z-isomers)
Nifedipine Impurity 31 (Mixture of E/Z-isomers)
CAS No.80742-13-8
Chemical FormulaC19H18N4O6
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 32 structure
32
硝苯地平杂质32Nifedipine Impurity 32
Nifedipine Impurity 32
CAS No.76093-34-0
Chemical FormulaC16H16N2O6
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 33 structure
33
硝苯地平杂质33Nifedipine Impurity 33
Nifedipine Impurity 33
CAS No.34783-31-8
Chemical FormulaC16H14N2O7
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 34 structure
34
硝苯地平杂质34Nifedipine Impurity 34
Nifedipine Impurity 34
CAS No.6085-99-0
Chemical FormulaC9H10N5O2+·Br-
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 35 structure
35
硝苯地平杂质35Nifedipine Impurity 35
Nifedipine Impurity 35
CAS No.3958-57-4
Chemical FormulaC7H6BrNO2
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 36 structure
36
硝苯地平杂质36Nifedipine Impurity 36
Nifedipine Impurity 36
CAS No.824-39-5
Chemical FormulaC6H4NO3-·Na+
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 38 structure
38
硝苯地平杂质38Nifedipine Impurity 38
Nifedipine Impurity 38
CAS No.623-11-0
Chemical FormulaC7H7NO
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 41 structure
41
硝苯地平杂质41Nifedipine Impurity 41
Nifedipine Impurity 41
CAS No.77234-00-5
Chemical FormulaC17H17NO4
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 43 structure
43
硝苯地平杂质43Nifedipine Impurity 43
Nifedipine Impurity 43
CAS No.65962-15-4
Chemical FormulaC7H5Br2NO2
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 44 structure
44
硝苯地平杂质44Nifedipine Impurity 44
Nifedipine Impurity 44
CAS No.1009375-46-5
Chemical FormulaC11H12N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 45 structure
45
硝苯地平杂质45Nifedipine Impurity 45
Nifedipine Impurity 45
CAS No.88434-67-7
Chemical FormulaC15H12N2O6
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 47 structure
47
硝苯地平杂质47Nifedipine Impurity 47
Nifedipine Impurity 47
CAS No.80012-11-9
Chemical FormulaC5H9NO2
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 48 structure
48
硝苯地平杂质48Nifedipine Impurity 48
Nifedipine Impurity 48
CAS No.21731-17-9
Chemical FormulaC5H9NO2
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 54 structure
54
硝苯地平杂质54Nifedipine Impurity 54
Nifedipine Impurity 54
CAS No.111304-29-1
Chemical FormulaC12H11NO5
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 55 structure
55
硝苯地平杂质55Nifedipine Impurity 55
Nifedipine Impurity 55
CAS No.111304-31-5
Chemical FormulaC12H11NO5
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 56 structure
56
硝苯地平杂质56Nifedipine Impurity 56
Nifedipine Impurity 56
CAS No.100-05-0
Chemical FormulaC6H4N3O2+·Cl-
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 57 structure
57
硝苯地平杂质57Nifedipine Impurity 57
Nifedipine Impurity 57
CAS No.14018-17-8
Chemical FormulaC6H5N3O3
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 60 structure
60
硝苯地平杂质60Nifedipine Impurity 60
Nifedipine Impurity 60
CAS No.31212-28-9
Chemical FormulaC6H5NO5S
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 61 structure
61
硝苯地平杂质61Nifedipine Impurity 61
Nifedipine Impurity 61
CAS No.108139-80-6
Chemical FormulaC17H18N2O6
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 62 structure
62
硝苯地平杂质62Nifedipine Impurity 62
Nifedipine Impurity 62
CAS No.58966-24-8
Chemical FormulaC8H8ClNO2
Purity>95%询价On request
10mg25mg50mg100mg
Nifedipine Impurity 63 structure
63
硝苯地平杂质63Nifedipine Impurity 63
Nifedipine Impurity 63
CAS No.2229604-34-4
Chemical FormulaC10H13NO3
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

硝苯地平 —— 研究文献与合成路线Nifedipine — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 硝苯地平 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Nifedipine. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Glucotoxic conditions induce endoplasmic reticulum stress to cause caspase 3 mediated lamin B degradation in pancreatic β-cells: protection by nifedipine
    Syeda K, Mohammed AM, Arora DK, et al. · Biochemical pharmacology · 2013 · 被引 32cited 32
  2. A study of the photo-degradation kinetics of nifedipine by multivariate curve resolution analysis
    Shamsipur M, Hemmateenejad B, Akhond M, et al. · Journal of pharmaceutical and biomedical analysis · 2003 · 被引 24cited 24
  3. High-performance liquid chromatography of nifedipine, its metabolites and photochemical degradation products
    Pietta P, Rava A, Biondi P · Journal of chromatography · 1981 · 被引 61cited 61
  4. Determination of nitrobenzene potential genotoxic impurities in nifedipine with GC-MS
    Zhao X, Li C, Zeng H, et al. · Journal of pharmaceutical and biomedical analysis · 2024 · 被引 6cited 6
  5. Real-time in situ X-ray micro-computed tomography study of the effect of impurities on the crystallization of amorphous nifedipine
    Amano Y, Misawa T, Miyazaki T, et al. · Journal of pharmaceutical and biomedical analysis · 2023 · 被引 6cited 6
  6. Iron and transition metal transport into erythrocytes mediated by nifedipine degradation products and related compounds
    Savigni DL, Wege D, Cliff GS, et al. · Biochemical pharmacology · 2003 · 被引 8cited 8

合成与制备工艺专利Synthesis & process patents

  1. Use of a preparation based on nifedipine for treating vaginismus
    ANTROPOLI CARMINE · 公开号 EP2322177EP2322177 · 2011
  2. Nifedipine sustained-release preparation and preparation method thereof
    SHUMEI WU, KAN WANG, HONGYAN ZHANG, QIULIN LIU, et al. · 公开号 CN101507716CN101507716 · 2009
  3. Nifedipine sustained release preparation and preparing method thereof
    GUILAI WANG, YICAI GAO, GUIRONG SUN, KANG WU, et al. · 公开号 CN101229140CN101229140 · 2008
  4. Nifedipine controlled release preparation and preparation method thereof
    KUAIYAN LUO, YANG LIU, WEILIANG XU, DIANWU GUO · 公开号 CN101310712CN101310712 · 2008
  5. PROCESS FOR PREPARING NIFEDIPINE
    BERWE MATHIAS, DIEHL HERBERT, RITTNER KARL, WAHL KARL-HEINZ, et al. · 公开号 EP0993446EP0993446 · 2000

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

硝苯地平 杂质谱研究要点Nifedipine — impurity profiling notes

下面这些是拿到 硝苯地平 的 47 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 47 impurity entries for Nifedipine, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances